Ralmitaront
Small moleculeexperimental
Clinical trial activity
4 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Mar 1, 2016 (NCT02699372)
Timeline
Indications
Mechanism of action
- Trace amine-associated receptor 1PARTIAL AGONIST
TAAR1 partial agonist
Chemistry & pharmacology
Loading structure…
SMILES
CCc1[nH]nc(C(=O)Nc2ccc([C@H]3CNCCO3)cc2)c1C- Mol. weight
- 314.39 g/mol
- Lipinski Ro5
- Pass
- Rule of 3
- No
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL4594376 ↗
Also known as
- ro6889450
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04512066 | Phase 2 | Sep 8, 2020 | Roche |
| NCT03669640 | Phase 2 | Nov 13, 2018 | Roche |
| NCT06880328 | Phase 1 | Nov 7, 2018 | Roche |
| NCT02699372 | Phase 1 | Mar 1, 2016 | Roche |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Roche | For profit | 4 | 4 | 2 | 2016 |
1 organizations
Page 1 / 1